Gene One Life Science to repurchase KRW 2.6 billion of debt early on bondholder put option exercise
Gene One Life Science set an early repurchase of KRW 2.5 billion of its 6th private convertible bonds. Total cash outlay set at KRW 2.6 billion, reflecting principal and interest; payment scheduled for Nov. 4, 2026. Transaction triggered by a bondholder put option; repurchase to be funded from internal cash. Bonds carr